As filed with the Securities and Exchange Commission on October 24, 2002
                                                      Registration No. 333-99201
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                           --------------------------

                                 AMENDMENT NO. 1
                                       TO
                                    FORM S-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933
                           --------------------------

                                   NUCO2 INC.
             (Exact Name of Registrant as Specified in Its Charter)


            Florida                                         65-0180800
--------------------------------------------------------------------------------
(State or Other Jurisdiction of                        (I.R.S. Employer
Incorporation or Organization)                        Identification Number)

                              2800 SE Market Place
                              Stuart, Florida 34997
                                 (772) 221-1754
--------------------------------------------------------------------------------
               (Address, Including Zip Code, and Telephone Number,
        Including Area Code, of Registrant's Principal Executive Offices)

                             Eric M. Wechsler, Esq.
                                 General Counsel
                                   NuCo2 Inc.
                              2800 SE Market Place
                              Stuart, Florida 34997
                                 (772) 221-1754
--------------------------------------------------------------------------------
            (Name, Address, Including Zip Code, and Telephone Number,
              Including Area Code, of Agent For Service of Process)

                    ----------------------------------------
                                   Copies to:
                              Steven Wolosky, Esq.
                 Olshan Grundman Frome Rosenzweig & Wolosky LLP
                                 505 Park Avenue
                            New York, New York 10022
                                 (212) 753-7200
                    ----------------------------------------

            Approximate  date of  commencement  of proposed  sale to the public:
From time to time after this Registration Statement becomes effective.

                    ----------------------------------------

            If the only  securities  being  registered  on this  Form are  being
offered pursuant to dividend or interest  reinvestment  plans,  please check the
following box. / /

            If any of the  securities  being  registered  on this Form are to be
offered  on a  delayed  or  continuous  basis  pursuant  to Rule 415  under  the
Securities Act of 1933,  other than  securities  offered only in connection with
dividend or interest reinvestment plans, please check the following box. /X/

            If this  Form is  filed to  register  additional  securities  for an
offering  pursuant to Rule 462(b)  under the  Securities  Act,  please check the
following box and list the Securities Act  registration  statement number of the
earlier effective registration statement for the same offering. / /

            If this Form is a  post-effective  amendment  filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act  registration   statement  number  of  the  earlier  effective  registration
statement for the same offering. / /

            If delivery  of the  prospectus  is expected to be made  pursuant to
Rule 434, please check the following box. / /




            The  Registrant  hereby amends this  Registration  Statement on such
date or  dates as may be  necessary  to  delay  its  effective  date  until  the
Registrant shall file a further  amendment which  specifically  states that this
Registration  Statement  shall  thereafter  become  effective in accordance with
Section 8(a) of the Securities Act of 1933 or until the  Registration  Statement
shall become  effective on such date as the Securities  and Exchange  Commission
(the "SEC"), acting pursuant to said Section 8(a), may determine.






The  information in this  prospectus is not complete and may be changed.  We may
not sell  these  securities  until the  registration  statement  filed  with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to  sell  these  securities  and it is not  soliciting  an  offer  to buy  these
securities in any state where the offer or sale is not permitted.

                  SUBJECT TO COMPLETION, DATED OCTOBER 24, 2002

                                   PROSPECTUS

                        1,663,846 SHARES OF COMMON STOCK

                                   NUCO2 INC.


            The selling  shareholders listed in this prospectus are offering and
selling from time to time up to  1,663,846  shares of common stock of NuCo2 Inc.
We will not receive any of the proceeds from such sale.


            Our common stock is listed on The Nasdaq  National  Market under the
symbol  "NUCO." The last reported sale price for the common stock on October 23,
2002 was $8.70 per share.


            The selling  shareholders  may sell the securities from time to time
on any stock  exchange or automated  interdealer  quotation  system on which the
securities are listed, in the  over-the-counter  market, in privately negotiated
transactions or otherwise, at fixed prices that may be changed, at market prices
prevailing at the time of sale, at prices related to prevailing market prices or
at prices otherwise negotiated.

            Our principal executive offices are located at 2800 SE Market Place,
Stuart, Florida 34997. Our telephone number is (772) 221-1754.


--------------------------------------------------------------------------------

THIS INVESTMENT  INVOLVES A HIGH DEGREE OF RISK. SEE "RISK FACTORS" BEGINNING ON
PAGE 4.
--------------------------------------------------------------------------------


--------------------------------------------------------------------------------

Neither  the  Securities  and  Exchange  Commission  nor  any  state  securities
commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete.

--------------------------------------------------------------------------------


                The date of this prospectus is October 24, 2002.







                                TABLE OF CONTENTS

                                                                            PAGE
                                                                            ----


Prospectus Summary...........................................................3
The Company..................................................................3
Risk Factors.................................................................4
Where You Can Find More Information.........................................10
Special Note Regarding Forwarding-Looking Statements........................11
Incorporation By Reference..................................................11
Use of Proceeds.............................................................12
Selling Shareholders........................................................12
Plan of Distribution........................................................14
Legal Matters...............................................................15
Experts.....................................................................15



                                      -2-






                               PROSPECTUS SUMMARY


            The selling  shareholders  listed in this  prospectus  may offer and
sell from time to time up to 1,663,846 shares of common stock purchased directly
from NuCo2 Inc. in a private  placement  in August  2002.  We agreed to register
with the Securities  and Exchange  Commission the resale of the shares of common
stock purchased by the selling shareholders.


                                   THE COMPANY

            Founded in 1990,  NuCo2 Inc. is, we believe,  the  nation's  leading
supplier of bulk carbon dioxide (CO2) systems for carbonating fountain beverages
based on the number of bulk CO2 systems  leased to customers.  Bulk CO2 involves
use of a cryogenic vessel delivered to a customer's site, which preserves CO2 in
its liquid  form and then  converts  the liquid  product  to  gaseous  CO2,  the
necessary  ingredient  for  beverage  carbonation.  This  is  a  relatively  new
technology  with  clear  advantages  over  high  pressure  CO2.  Some  of  these
advantages are

            o   consistent and improved beverage quality,
            o   increased product yields,
            o   reduced employee handling and storage requirements,
            o   greater productivity,
            o   elimination of downtime and product waste, and
            o   enhanced safety.


            Presently,  CO2 is supplied in most  instances to fountain  beverage
users in the form of gas,  which is  transported  and  stored  in high  pressure
cylinders.   High  pressure  cylinders  have  been  the  predominant  method  of
carbonating fountain beverages for almost 100 years. High pressure cylinders may
be less expensive than bulk CO2 systems for low volume users of CO2. Our ability
to grow is  dependent  on the  success of our  marketing  efforts to acquire new
customers and their  acceptance  of bulk CO2 systems as a  replacement  for high
pressure cylinders.

            We believe  we are the first and only  company  in our  industry  to
operate a national  network for bulk CO2. We have 101  service  locations  in 45
states servicing approximately 71,000 customers. Among our customers are many of
the major national and regional  restaurant and convenience store chains,  movie
theater operators, theme parks, resorts and sports venues.

            We are incorporated in Florida and our common stock is traded on The
Nasdaq  National  Market under the symbol "NUCO".  We have been a public company
since December 1995.

                                      -3-





                                  RISK FACTORS


            THE  PURCHASE OF OUR COMMON  SHARES  INVOLVES A HIGH DEGREE OF RISK.
YOU  SHOULD  CAREFULLY  CONSIDER  THE  FOLLOWING  RISK  FACTORS  AND  THE  OTHER
INFORMATION IN THIS PROSPECTUS BEFORE DECIDING TO INVEST IN OUR COMMON SHARES.

WE HAVE INCURRED LOSSES SINCE OUR INCEPTION AND FACE  UNCERTAINTY IN OUR ABILITY
TO BECOME A PROFITABLE COMPANY.


            We have incurred substantial losses since our inception in 1990. Our
net loss was $9.4  million for fiscal  2000,  $15.5  million for fiscal 2001 and
$11.0  million  for fiscal  2002.  We are  uncertain  whether we will  install a
sufficient number of our bulk CO2 systems or obtain sufficient market acceptance
to allow us to  achieve  or  sustain  profitability.  Our  losses  to date  have
resulted  primarily  from expenses we incurred in building a sales and marketing
organization,   adding  administrative   personnel  and  developing  a  national
infrastructure  to support the rapid growth in the number of our installed  base
of bulk CO2 systems. The cost of this expansion and the significant depreciation
expense of our installed  base of bulk CO2 systems have resulted in  significant
operating losses to date and accumulated net losses of $53.0 million at June 30,
2002.


WE HAVE SUBSTANTIAL INDEBTEDNESS AND OUR OBLIGATION TO SERVICE THAT INDEBTEDNESS
COULD DIVERT FUNDS FROM  OPERATIONS  AND LIMIT OUR ABILITY TO OBTAIN  ADDITIONAL
FUNDING TO EXPAND OUR BUSINESS.


            As of June  30,  2002,  we had  outstanding  indebtedness  of  $88.0
million,  which included $48.0 million under our revolving  credit  facility and
$40.0 million of our 12% senior subordinated promissory notes due 2004 and 2005.


            If we are unable to  generate  sufficient  cash flow to service  our
indebtedness, we will have to:

        o   reduce or delay planned capital expenditures,
        o   sell assets,
        o   restructure or refinance our indebtedness or
        o   seek additional equity capital.

            We are uncertain  whether any of these strategies can be effected on
satisfactory  terms,  if at all,  particularly  in light of our high  levels  of
indebtedness.  In addition,  the extent to which we continue to have substantial
indebtedness could have significant consequences, including:

        o   our ability to obtain additional financing in the future for working
            capital,  capital  expenditures,  product  research and development,
            acquisitions and other general corporate  purposes may be materially
            limited or impaired,

        o   a substantial  portion of our cash flow from  operations may need to
            be  dedicated  to the payment of interest  on our  indebtedness  and
            therefore not available to finance our business, and

                                      -4-


        o   our high  degree  of  indebtedness  may make us more  vulnerable  to
            economic  downturns,  limit our  ability  to  withstand  competitive
            pressures  or reduce  our  flexibility  in  responding  to  changing
            business and economic conditions.


            Also, our lenders require that we comply with financial and business
covenants. If we fail to maintain these covenants,  our lenders could declare us
in default.  They could demand the repayment of our indebtedness to them if this
default  were not cured or  waived.  At  various  times in the past we have been
unable to meet certain covenants and have had to obtain waivers or modifications
of terms  from our  lenders.  Circumstances  may  result in our having to obtain
waivers or further modifications in the future.


OUR FUTURE  OPERATING  RESULTS REMAIN  UNCERTAIN  DESPITE THE GROWTH RATE IN OUR
REVENUE.


            You should not consider growth rates in our revenue to be indicative
of growth rates in our operating results.  In addition,  you should not consider
prior growth rates in our revenue to be indicative of future growth rates in our
revenue. The timing and amount of future revenues will depend almost entirely on
our ability to obtain  agreements with new customers to install bulk CO2 systems
and use our services.  Our future operating results will depend on many factors,
including:

        o   the level of product and price competition,
        o   the ability to manage our growth,
        o   the ability to hire additional employees, and
        o   the ability to control costs.

WE LACK  PRODUCT  DIVERSITY,  AND  OUR  BUSINESS  DEPENDS  ON  CONTINUED  MARKET
ACCEPTANCE  BY THE  FOOD AND  BEVERAGE  INDUSTRY  OF OUR  PRODUCT  AND  CONSUMER
PREFERENCE FOR CARBONATED BEVERAGES.

            We depend on continued market  acceptance of our bulk CO2 systems by
the food and beverage  industry,  which  accounts for  approximately  95% of our
revenues.  Unlike  many of our  competitors  for whom  bulk  CO2 is a  secondary
business,  we have no material  lines of business other than the leasing of bulk
CO2 systems and the sale of CO2. We do not  anticipate  diversifying  into other
product or service  lines in the future.  The retail  beverage  CO2  industry is
mature,  with only limited growth in total demand for CO2 foreseen.  Our ability
to grow is dependent  upon the success of our  marketing  efforts to acquire new
customers and their  acceptance  of bulk CO2 systems as a  replacement  for high
pressure CO2  cylinders.  While the food and beverage  industry to date has been
receptive to bulk CO2 systems,  we cannot be certain that the operating  results
of our installed  base of bulk CO2 systems will continue to be favorable or that
past results will be indicative of future market acceptance of our service.


            In  addition,  any  recession  experienced  by the food and beverage
industry or any significant  shift in consumer  preferences away from carbonated
beverages to other types of beverages would result in a loss of revenues,  which
would adversely affect our financial condition and results of operations and our
ability to service our indebtedness.

                                      -5-





OUR  MARKET IS HIGHLY  COMPETITIVE  AND OUR  INABILITY  TO  RESPOND  TO  VARIOUS
COMPETITIVE  FACTORS MAY RESULT IN A LOSS OF CURRENT  CUSTOMERS AND A FAILURE TO
ATTRACT NEW CUSTOMERS.

            The industry in which we operate is highly  competitive.  We compete
regionally  with  several  direct  competitors.  We cannot be certain that these
competitors  will not  substantially  increase their  installed base of bulk CO2
systems and expand their service nationwide. Because there are no major barriers
to entry, we also face the risk of a  well-capitalized  competitor's  entry into
our  existing  or  future  markets.  In  addition,   we  compete  with  numerous
distributors of bulk and high pressure CO2, including:

        o   industrial gas and welding supply companies,
        o   specialty gas companies,
        o   restaurant and grocery supply companies and
        o   fountain supply companies.

            These suppliers vary widely in size.  Some of our  competitors  have
significantly  greater financial,  technical or marketing  resources than we do.
Our competitors might succeed in developing  technologies,  products or services
that are  superior,  less costly or more widely used than those that have or are
being developed by us or that would render our technologies or products obsolete
or noncompetitive.  In addition,  competitors may have an advantage over us with
customers  who prefer  dealing with one company that can supply bulk CO2 as well
as  fountain  syrup.  We  cannot  be  certain  that we  will be able to  compete
effectively with current or future competitors.

OUR  INABILITY  TO  MANAGE  GROWTH  MAY  OVEREXTEND  OUR  MANAGEMENT  AND  OTHER
RESOURCES,  CAUSING  INEFFICIENCIES  WHICH MAY  ADVERSELY  AFFECT OUR  OPERATING
RESULTS.

            We have  experienced  rapid  growth and intend to continue to expand
our operations aggressively. Because of our limited product line, we must expand
operations to become profitable. We may be unable to:

        o   manage  effectively the expansion of our  operations,
        o   implement and develop our systems,  procedures or controls,
        o   adequately  support our operations or
        o   achieve and manage the currently projected installations of bulk CO2
            systems.

            If we  are  unable  to  manage  growth  effectively,  our  business,
financial  condition  and results of  operations  and our ability to service our
indebtedness  could be seriously harmed. The growth in the size and scale of our
business  has  placed,  and we expect  it will  continue  to place,  significant
demands on our personnel and operating systems. Our additional planned expansion
may further strain management and other resources.  Our ability to manage growth
effectively will depend on our ability to

        o   improve our operating systems,
        o   expand, train and manage our employee base and
        o   develop additional service capacity.

                                      -6-





WE ARE DEPENDENT ON  THIRD-PARTY  SUPPLIERS AND IF THESE  SUPPLIERS  CEASE DOING
BUSINESS WITH US, WE MAY HAVE DIFFICULTY  FINDING SUITABLE  REPLACEMENTS TO MEET
OUR NEEDS.


            We do not conduct  manufacturing  operations  and  depend,  and will
continue to depend,  on outside  parties for the manufacture of bulk CO2 systems
and components. We intend to significantly expand our installed base of bulk CO2
systems.  Our  expansion  may be limited by the  manufacturing  capacity  of our
third-party   manufacturers.   Manufacturers   may  not  be  able  to  meet  our
manufacturing  needs  in a  satisfactory  and  timely  manner.  If  there  is an
unanticipated  increase in demand for bulk CO2 systems, we may be unable to meet
such demand due to manufacturing constraints.  We purchase bulk CO2 systems from
Chart  Industries,  Inc.  and Taylor  Wharton  Cryogenics  (a division of Harsco
Corporation),  the two major  manufacturers  of bulk CO2 systems.  Should either
manufacturer  cease  manufacturing  bulk CO2  systems,  we would be  required to
locate additional suppliers.  We may be unable to locate alternate manufacturers
on a  timely  basis.  A delay in the  supply  of bulk CO2  systems  could  cause
potential  customers  to delay their  decision to  purchase  our  services or to
choose not to purchase our  services.  This would result in delays in or loss of
future revenues.

            In  addition,  we purchase CO2 for resale to our  customers.  In May
1997, we entered into a ten year supply  contract  with The BOC Group,  Inc. for
the  purchase  of bulk CO2.  In the event  that BOC is  unable  to  fulfill  our
requirements,  we would have to locate additional suppliers. A delay in locating
additional  suppliers or our  inability  to locate  additional  suppliers  would
result in loss of revenues, which would adversely affect our financial condition
and results of operations and our ability to service our indebtedness.

YOU MAY NOT BE ABLE TO SELL OUR  STOCK ON TERMS  FAVORABLE  TO YOU  BECAUSE  OUR
COMMON SHARE PRICE HAS BEEN AND MAY CONTINUE TO BE VOLATILE.

            Our  common  share  price  has  fluctuated  substantially  since our
initial public  offering in December 1995. The market price of our common shares
could decline from current levels or continue to fluctuate.  The market price of
our common shares may be significantly affected by the following factors:

        o   announcements  of  technological  innovations  or  new  products  or
            services by us or our competitors,
        o   trends and fluctuations in the use of bulk CO2 systems,
        o   timing  of bulk CO2  systems  installations  relative  to  financial
            reporting periods,
        o   release of reports,
        o   operating results below expectations,
        o   changes  in,  or  our  failure  to  meet,   financial  estimates  by
            securities analysts,
        o   industry developments,
        o   market acceptance of bulk CO2 systems,
        o   economic and other external factors, and
        o   period-to-period fluctuations in our financial results.

            In  addition,   the  securities  markets  have  from  time  to  time
experienced  significant price and volume fluctuations that are unrelated to the
operating  performance of particular  companies.  These market  fluctuations may
also materially and adversely affect the market price of our common shares.

                                      -7-





OUR OPERATING  RESULTS MAY FLUCTUATE DUE TO SEASONALITY  SINCE CONSUMERS TEND TO
DRINK FEWER QUANTITIES OF CARBONATED BEVERAGES DURING THE WINTER MONTHS.

            Approximately  9% of our  bulk  CO2  customers  lease  our  bulk CO2
systems  and,  in  addition,  are  billed by the  pound for bulk CO2  delivered.
Approximately  13% of our bulk CO2  customers own their own bulk CO2 systems and
are billed by the pound for all CO2  delivered.  We believe  that, on a relative
basis,  customers  purchasing  bulk CO2 by the pound tend to consume less CO2 in
the winter months. Our sales to such customers will be correspondingly  lower in
times of cold or inclement weather.  We cannot be certain,  however,  that these
seasonal trends will continue.  Consequently,  we are unable to predict revenues
for any future quarter with any significant degree of accuracy.

FOR THE FORESEEABLE FUTURE,  YOUR ONLY RETURN ON INVESTMENT,  IF ANY, WILL OCCUR
ON THE SALE OF OUR STOCK BECAUSE WE DO NOT INTEND TO PAY DIVIDENDS.

            We have never  declared  or paid any cash  dividends  on our capital
stock.  We currently  intend to retain any future  earnings for funding  growth.
Therefore,  we do not expect to pay any dividends in the foreseeable  future. In
addition,  the payment of cash dividends is restricted by financial covenants in
our loan agreements.

OUR OPERATING  RESULTS ARE AFFECTED BY RISING  INTEREST  RATES SINCE MORE OF OUR
CASH FLOW WILL BE NEEDED TO SERVICE OUR INDEBTEDNESS.

            The interest rate on our revolving  credit facility  fluctuates with
market  interest  rates  resulting in greater  interest costs in times of rising
interest  rates.  Consequently,  our  profitability  is  sensitive to changes in
interest rates.

OUR  INSURANCE  POLICIES MAY NOT COVER ALL  OPERATING  RISKS AND A CASUALTY LOSS
BEYOND OUR COVERAGE COULD NEGATIVELY IMPACT OUR BUSINESS.


            Our operations are subject to all of the operating hazards and risks
normally  incidental to handling,  storing and transporting CO2. As a compressed
gas, CO2 is classified as a hazardous  material.  We maintain insurance policies
in such  amounts and with such  coverages  and  deductibles  that we believe are
reasonable and prudent. We cannot assure you that our insurance will be adequate
to protect us from all  liabilities  and expenses that may arise from claims for
personal and property  damage arising in the ordinary course of business or that
current  levels of insurance  will be  maintained  or  available  at  economical
prices.  If a  significant  liability  claim is  brought  against us that is not
covered  by  insurance,  we may have to pay the claim with our own funds and our
financial  condition and ability to service our indebtedness  could be seriously
harmed.

                                      -8-





OUR BUSINESS IS SUBJECT TO EXTENSIVE GOVERNMENTAL REGULATION, WHICH MAY INCREASE
OUR  COST  OF  DOING  BUSINESS.  IN  ADDITION,  FAILURE  TO  COMPLY  WITH  THESE
REGULATIONS  MAY  SUBJECT US TO FINES,  PENALTIES  AND/OR  INJUNCTIONS  THAT MAY
ADVERSELY AFFECT OUR OPERATING RESULTS.

            Our  business is subject to federal  and state laws and  regulations
adopted  for the  protection  of the  environment,  the health and safety of our
employees and users of our products and services. The transportation of bulk CO2
is subject to regulation by various federal, state and local agencies, including
the U.S. Department of Transportation.  These regulatory  authorities have broad
powers, and we are subject to regulatory and legislative changes that can affect
the  economics of our industry by  requiring  changes in operating  practices or
influencing  the demand for and the cost of providing  services.  A  significant
increase in the cost of our operations  could  adversely  affect our chances for
profitability.

OUR OFFICERS AND  DIRECTORS ARE ABLE TO EXERT  SIGNIFICANT  CONTROL OVER MATTERS
REQUIRING  SHAREHOLDER  APPROVAL,  WHICH MAY  ADVERSELY  AFFECT  THE PRICE  THAT
INVESTORS ARE WILLING TO PAY FOR OUR COMMON STOCK.

            Executive  officers,  directors  and entities  affiliated  with them
beneficially own, in the aggregate,  approximately 29% of our outstanding common
shares  (including  common shares issuable upon conversion of preferred  stock).
These shareholders, if acting together, would be able to significantly influence
all matters requiring  approval by our  shareholders,  including the election of
directors  and the  approval  of  significant  corporate  transactions,  such as
mergers  or other  business  combination  transactions.  This  concentration  of
ownership may also have the effect of delaying or preventing an  acquisition  or
change in control of our company,  which could have a material adverse effect on
our common share price.

OUR PREFERRED STOCK AND PROVISIONS OF OUR CHARTER AND FLORIDA LAW MAY NEGATIVELY
AFFECT THE ABILITY OF A POTENTIAL  BUYER TO PURCHASE ALL OR SOME OF OUR STOCK AT
AN OTHERWISE ADVANTAGEOUS PRICE, WHICH MAY LIMIT THE PRICE INVESTORS ARE WILLING
TO PAY FOR OUR COMMON STOCK.

            Our common  shares are  subordinate  to all  outstanding  classes of
preferred  stock in the  payment of  dividends  and other  distributions  on our
stock, including distributions upon liquidation or dissolution of NuCo2. We have
outstanding  two  series  of  preferred   stock,  the  Series  A  8%  cumulative
convertible preferred stock and the Series B 8% cumulative convertible preferred
stock.  Our board of directors  has the  authority to issue up to an  additional
4,992,500  shares of preferred  stock.  If we designate or issue other series of
preferred  stock, it will create  additional  securities that will have dividend
and  liquidation  preferences  over the common shares.  If we issue  convertible
preferred  stock, a subsequent  conversion may dilute the current  shareholders'
interest.  Without any further  vote or action on the part of the  shareholders,
our board of directors  will have the authority to determine the price,  rights,
preferences,  privileges and restrictions of the preferred  stock.  Although the
issuance of preferred stock will provide us with  flexibility in connection with
possible  acquisitions and other corporate  purposes,  the issuance of preferred
stock may make it more  difficult for a third party to acquire a majority of our
outstanding voting stock.

            We are subject to several  anti-takeover  provisions that apply to a
public  corporation  organized  under Florida law.  These  provisions  generally
require  that  an  "affiliated  transaction"  (certain  transactions  between  a
corporation and a holder of more than 10% of its outstanding  voting securities)
must be  approved  by a majority of  disinterested  directors  or the holders of
two-thirds  of the  voting  shares  not  beneficially  owned  by an  "interested
shareholder."  Additionally,  "control  shares"  (shares  acquired  in excess of

                                      -9-





certain specified  thresholds)  acquired in specified control share acquisitions
have  voting  rights  only to the extent  conferred  by  resolution  approved by
shareholders, excluding holders of shares defined as "interested shares."

            A Florida corporation may opt out of the Florida  anti-takeover laws
if its articles of incorporation or, depending on the provision in question, its
bylaws so provide.  We have not opted out of the provisions of the anti-takeover
laws.  Consequently,  these  laws  could  prohibit  or delay a  merger  or other
takeover or change of control and may discourage  attempts by other companies to
acquire us.

FUTURE SALES OF SHARES MAY  ADVERSELY  AFFECT OUR STOCK PRICE SINCE ANY INCREASE
IN THE AMOUNT OF OUTSTANDING SHARES MAY HAVE A DILUTIVE EFFECT ON OUR STOCK.


            If our shareholders sell substantial amounts of our common shares in
the public market, the market price of our common shares could fall. These sales
could be due to shares issued upon exercise of outstanding  options and warrants
and upon  conversion  of  preferred  stock.  These sales also might make it more
difficult for us to sell equity or equity-related  securities in the future at a
time and price that we deem appropriate.  We have outstanding  options under our
1995 stock option  plan,  directors'  stock  option plan and options  granted to
directors  to purchase an aggregate  of  1,311,950  common  shares at an average
exercise  price of $9.95 per share  and  outstanding  warrants  to  purchase  an
aggregate of 1,416,462  common shares at an average exercise price of $10.06 per
share.  In addition,  we also have  outstanding  Series A and Series B preferred
stock that is  convertible  at $9.28 and $12.92  per share,  respectively,  into
641,803 and 205,342 common shares, respectively.

                       WHERE YOU CAN FIND MORE INFORMATION

            We have filed a registration  statement on Form S-3 with the SEC for
our common shares offered in this offering. This prospectus does not contain all
the information set forth in the registration statement. You should refer to the
registration statement and its exhibits for additional information.  Whenever we
make references in this prospectus to any of our contracts,  agreements or other
documents,  the references are not necessarily  complete and you should refer to
the exhibits attached to the registration statement for the copies of the actual
contract, agreement or other document.

            You should rely only on the information and representations provided
or incorporated by reference in this  prospectus or any related  supplement.  We
have not authorized anyone else to provide you with different  information.  The
selling  shareholders  will not make an offer to sell these  shares in any state
where the offer is not permitted.  You should not assume that the information in
this prospectus or any supplement is accurate as of any date other than the date
on the front of those documents.

            The SEC  maintains  an Internet  site at  http://www.sec.gov,  which
contains  reports,  proxy and  information  statements,  and  other  information
regarding  us. You may also read and copy any  document  we file with the SEC at
its Public  Reference  Room, 450 Fifth Street,  N.W.,  Washington,  D.C.  20549.
Please call the SEC at 1-800-SEC-0330  for further  information on the operation
of the Public Reference Room.

                                      -10-





            Our common shares are listed on The Nasdaq  National Market and such
reports and other  information may also be inspected at the offices of Nasdaq at
1735 K Street, N.W., Washington, DC 20006-1500.  Additional information about us
is available over the Internet at our web site at http://www.nuco2.com.


                SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

            This  prospectus and documents  incorporated  by reference into this
prospectus contain forward-looking  statements within the meaning of Section 27A
of the  Securities  Act of 1933, as amended,  and Section 21E of the  Securities
Exchange Act of 1934, as amended,  that are not historical  facts but rather are
based on current expectations,  estimates and projections about our business and
industry, our beliefs and assumptions.  Words such as "anticipates",  "expects",
"intends",  "plans",  "believes",  "seeks",  "estimates" and variations of these
words  and  similar   expressions  are  intended  to  identify   forward-looking
statements.  These  statements are not guarantees of future  performance and are
subject to certain risks,  uncertainties  and other  factors,  some of which are
beyond our control,  are difficult to predict and could cause actual  results to
differ  materially  from those  expressed or forecasted  in the  forward-looking
statements.  These risks and  uncertainties  include  those  described  in "Risk
Factors"  beginning on page 4 and  elsewhere in this  prospectus  and  documents
incorporated by reference into this  prospectus.  You are cautioned not to place
undue  reliance  on  these   forward-looking   statements,   which  reflect  our
management's  view only as of the date of this  prospectus  or as of the date of
any document  incorporated  by reference into this  prospectus.  We undertake no
obligation  to update these  statements  or publicly  release the results of any
revisions to the  forward-looking  statements that we may make to reflect events
or  circumstances  after the date of this prospectus or the date of any document
incorporated  into this prospectus or to reflect the occurrence of unanticipated
events.

                           INCORPORATION BY REFERENCE


            The SEC allows us to  "incorporate  by reference" the information we
file with them, which means that we can disclose important information to you by
referring to those  documents.  The  information  we incorporate by reference is
considered to be a part of this  prospectus and  information  that we file later
with  the SEC  will  automatically  update  and  replace  this  information.  We
incorporate  by reference the documents  listed below and any future  filings we
make with the SEC under  Sections  13(a),  13(c),  14 or 15(d) of the Securities
Exchange Act of 1934, as amended (the "Exchange  Act") prior to the  termination
of this offering:


(1)      Our Annual Report on Form 10-K for the fiscal year ended June 30, 2002;

(2)      Our Current Report on Form 8-K dated July 12, 2002;

(3)      Our Current Report on Form 8-K dated August 26, 2002;

(4)      Our Current Report on Form 8-K dated September 18, 2002; and

(5)      The  description  of our common  shares  contained in our  Registration
         Statement on Form 8-A dated December 11, 1995.

                                      -11-




            You may request a copy of these filings  (excluding  the exhibits to
such filings which we have not  specifically  incorporated  by reference in such
filings) at no cost, by writing or telephoning us at the following address:


                                   NuCo2 Inc.
                              2800 SE Market Place
                              Stuart, Florida 34997
                           Attention: General Counsel
                                 (772) 221-1754

                                 USE OF PROCEEDS

            The  common  shares  offered  hereby  are being  registered  for the
account of the  selling  stockholders  identified  in this  prospectus.  All net
proceeds  from the sale of the common  shares  will go to the  shareholders  who
offer and sell their  shares.  Accordingly,  we will not receive any part of the
proceeds from such sales.

                              SELLING SHAREHOLDERS

            The  following  table  sets  forth  the name of each of the  selling
shareholders,  the number of shares  beneficially  owned by each of the  selling
shareholders, the number of shares that may be offered under this prospectus and
the number of common shares owned by each of the selling  shareholders after the
offering is  completed.  None of the selling  shareholders  has been an officer,
director or had any material relationship with us within the past three years.
                                                                                        Number of Common
                                            Number of                                  Shares/Percentage of
                                         Common Shares                                  Class to Be Owned
                                       Owned Prior to the     Number of Common         After Completion of
Name                                        Offering        Shares to be Offered           the Offering
----                                        ---------             -------                  ------------

Gulfstream Partners, L.P.                     85,000              85,000                       0/0.0%
Colonial Fund, LLC                            50,000              50,000                       0/0.0%
Greenwich Investment Fund, LP                 17,700              15,000                       2,700/*
Robert G. Schiro                              11,282              11,282                       0/0.0%
Far West Capital Partners, LP                 22,564              22,564                       0/0.0%
Hermes Partners, L.P.                         55,000              55,000                       0/0.0%
Ultra Hermes Fund Ltd.                        65,000              65,000                       0/0.0%
Cohanzick Partners, LP                        60,000              60,000                       0/0.0%
Ashford Capital Partners, L.P.               175,000             175,000                       0/0.0%
David Ross                                     7,500               2,500                       5,000/*
Praxis II Partners A/C #2                      7,500               2,500                       5,000/*
Paul Ross                                     22,000              15,000                       7,000/*
Stuart Ross                                   22,000              15,000                       7,000/*
Akkad                                        900,000             400,000                       500,000/4.7%
Payoff and Co.                               190,000             100,000                       90,000/*

                                      -12-





Northcabin & Co.                             100,000             100,000                       0/0.0%
Ernst Ohnell                                  50,000              50,000                       0/0.0%
Saw Mill Investments, LLC                     60,000              60,000                       0/0.0%
Edward A. Fox                                 30,000              30,000                       0/0.0%
Marlin Fund, L.P.                             34,000              34,000                       0/0.0%
Marlin Fund II, L.P.                           6,000               6,000                       0/0.0%
Marlin Fund Offshore, Limited                 60,000              60,000                       0/0.0%
Pequot Scout Fund, L.P.                      485,700             150,000                       335,700/3.2%
Pequot Navigator Offshore Fund, Inc.         188,400             100,000                       88,400/*


--------------
*    Less than one percent.

            The  following  table  lists the names of the people who have voting
and  investment  control  of the shares of our  common  stock for those  selling
shareholders that are not individuals.


NAME OF THE ENTITY                                    NAME OF THE PERSON
------------------                                    ------------------
Gulfstream Partners, L.P.                             Mr. Piers M. MacDonald
Colonial Fund, LLC                                    Mr. Cary G. Brody
Greenwich Investment Fund, LP                         Mr. Lawrence J. Rawson
                                                      Mr. Michael C. Esposito
Far West Capital Partners, LP                         Mr. Robert G. Schiro
Hermes Partners, L.P.                                 Mr. Paul Flather
Ultra Hermes Fund Ltd.                                Mr. Paul Flather
Cohanzick Partners, LP                                Mr. David Sherman
Ashford Capital Partners, L.P.                        Mr. Theodore H. Ashford
Praxis II Partners A/C #2                             Mr. David Ross
                                                      Mr. Paul Ross
                                                      Mr. Stuart Ross
Akkad                                                 Mr. Ralph Wanger
                                                      Mr. Church McQuaid
Payoff and Co.                                        Mr. Rob Mohn
Northcabin & Co.                                      Mr. Rob Mohn
Saw Mill Investments, LLC                             Mr. Howard Unger
Marlin Fund, L.P.                                     Mr. Michael W. Masters
Marlin Fund II, L.P.                                  Mr. Michael W. Masters
Marlin Fund Offshore, Limited                         Mr. Michael W. Masters
Pequot Scout Fund, L.P.                               Mr. Arthur J. Samberg
                                                      Mr. Kevin O'Brien
Pequot Navigator Offshore Fund, Inc.                  Mr. Arthur J. Samberg
                                                      Mr. Kevin O'Brien

            Based  on   information   provided  by  the  selling   shareholders,
Gulfstream  Partners,  L.P.,  Akkad,  Payoff  and Co. and  Northcabin  & Co. are
affiliates of  broker-dealers  within the meaning of Rule 405 of the  Securities
Act of 1933. Each of these selling  shareholders  purchased shares of our common

                                      -13-





stock in the ordinary  course of business  and at the time of their  purchase of
our common stock, these selling shareholders had no agreements or understandings
directly or indirectly with any person to distribute our common stock.

            Our  registration of the shares included in this prospectus does not
necessarily mean that each of the selling  stockholders  will opt to sell any of
the shares offered  hereby.  The shares  covered by this  prospectus may be sold
from time to time by the selling stockholders so long as this prospectus remains
in effect.

                              PLAN OF DISTRIBUTION

            We will not receive any proceeds  from the sale of the shares by the
selling  shareholders.  The  selling  shareholders  will  receive all of the net
proceeds  from the sale of the shares under this  prospectus.  Any or all of the
shares offered by the selling  shareholders may be offered for sale and sold by,
or on behalf of, the selling  shareholders from time to time in varying amounts,
including  in  block  transactions,  on  the  Nasdaq  National  Market,  or  the
over-the-counter market, in privately negotiated transactions,  or otherwise, at
prices  prevailing  in such  market or as may be  negotiated  at the time of the
sale. The shares may be sold by the selling shareholders directly to one or more
purchasers,  through  agents  designated  from  time to  time  or to or  through
broker-dealers  designated from time to time. If the shares are publicly offered
through  broker-dealers  or  agents,  the  selling  shareholders  may enter into
agreements  with  respect  thereto.  Such  broker-dealers  or agents may receive
compensation  in the form of  discounts,  concessions  or  commissions  from the
selling shareholders,  and any such broker-dealers or agents that participate in
the  distribution  of the  shares  may be deemed to be  underwriters  within the
meaning of the Securities  Act, and any profit on the sale of the shares by them
and any discounts and commissions  might be deemed to be underwriting  discounts
or commissions under the Securities Act. Any such  broker-dealers and agents may
engage in  transactions  with, and perform  services for,  NuCo2.  At the time a
particular  offer of shares is made by the selling  shareholders,  to the extent
required,  a prospectus  supplement will be distributed which will set forth the
aggregate  number  of  shares  being  offered,  and the  terms of the  offering,
including  the  public  offering  price  thereof,  the  name  or  names  of  any
broker-dealers   or  agents,   any  discounts,   commissions   and  other  items
constituting  compensation  from, and the resulting net proceeds to, the selling
shareholders.

            In order to comply with the securities laws of certain states, sales
of shares  offered  hereby to the public in such states may be made only through
broker-dealers  who are  registered or licensed in such states.  Sales of shares
offered hereby must also be made by the selling  shareholders in compliance with
other applicable state securities laws and regulations.

            We have  agreed to bear  certain  expenses  of  registration  of the
shares  under  federal and state  securities  laws and of any  offering and sale
hereunder not including  certain  expenses,  such as  commissions  of dealers or
agents  and fees  attributable  to the sale of the  shares.  We have  agreed  to
indemnify  the  selling  shareholders  against  certain  liabilities,  including
certain potential liabilities under the Securities Act. The selling shareholders
have also agreed to indemnify us against certain liabilities,  including certain
potential liabilities under the Securities Act.

            The selling  shareholders  have represented to us that they have not
taken and currently do not plan to take any action  designed to or that resulted
in or may cause the  stabilization  or  manipulation  of the price of any of our

                                      -14-





securities to facilitate  the resale of the shares offered  hereby.  In general,
Rule 102 under  Regulation M prohibits any person  connected with a distribution
of securities  (a  "Distribution")  from directly or indirectly  bidding for, or
purchasing for any account in which he or she has a beneficial interest,  any of
such  securities or any right to purchase such  securities,  for a period of one
business  day before and after  completion  of his or her  participation  in the
distribution (we refer to that time period as the "Distribution Period").

            During  the  Distribution   Period,  Rule  104  under  Regulation  M
prohibits  the  selling  shareholders  and  any  other  persons  engaged  in the
Distribution  from engaging in any  stabilizing  bid or purchasing of our common
stock  except for the purpose of  preventing  or retarding a decline in the open
market  price of our common  stock.  No such  person may effect any  stabilizing
transaction  to facilitate  any offering at the market.  Inasmuch as the selling
shareholders  will be  reoffering  and reselling our common stock at the market,
Rule  104  prohibits  them  from  effecting  any   stabilizing   transaction  in
contravention of Rule 104 with respect to our common stock.

                                  LEGAL MATTERS

            The validity of the common  shares  offered  hereby have been passed
upon by Olshan  Grundman  Frome  Rosenzweig & Wolosky LLP, 505 Park Avenue,  New
York, New York 10022. Certain members of such firm own our common shares. Robert
L. Frome, a member of such firm, is one of our directors.

                                     EXPERTS

            The consolidated  financial statements of NuCo2 Inc. incorporated in
this  prospectus  by reference to our Annual  Report on Form 10-K for the fiscal
year ended June 30, 2002 have been so  incorporated in reliance on the report of
Margolin, Winer & Evens LLP, independent accountants,  given on the authority of
said firm as experts in auditing and accounting.

                                      -15-






                                   NUCO2 INC.


                                    1,663,846
                             SHARES OF COMMON STOCK

                                   ----------

                                   PROSPECTUS
                                   ----------


                               _____________, 2002

                                      -16-





                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS


ITEM 14.    Other Expenses of Issuance and Distribution.
-------     -------------------------------------------

            The following  table sets forth the various  expenses  which will be
paid  by us in  connection  with  the  securities  being  registered.  With  the
exception of the SEC registration fee, all amounts shown are estimates.

SEC registration fee.....................................$ 1,539.00
Legal fees and expenses (including Blue Sky fees)........$15,000.00
Accounting Fees and Expenses.............................$ 5,000.00
Miscellaneous............................................$ 1,461.00
                                                         ----------
            Total   .....................................$23,000.00

ITEM 15.    Indemnification of Directors and Officers.
-------     -----------------------------------------

            Except  as  hereinafter  set  forth,  there is no  statute,  charter
provision,  by-law,  contract or other  arrangement  under which any controlling
person,  director  or officer of the  Company is insured or  indemnified  in any
manner against liability which he may incur in his capacity as such.

            The Articles of Incorporation and Bylaws of the Company provide that
the Company may  indemnify  to the fullest  extent  permitted by Florida law any
person  whom  it  may  indemnify  thereunder,   including  directors,  officers,
employees and agents of the Company.

            The Company has obtained a directors'  and  officers'  insurance and
company  reimbursement  policy in the amount of $10,000,000.  The policy insures
directors and officers against  unindemnified loss arising from certain wrongful
acts in their capacities and would reimburse the Company for such loss for which
the Company has lawfully indemnified the directors and officers.

            Section  607.0850 of the Florida  Business  Corporation Act reads as
follows:

INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES, AND AGENTS.

(1)      A corporation  shall have power to indemnify any person who was or is a
         party to any  proceeding  (other than an action by, or in the right of,
         the  corporation),  by reason of the fact that he is or was a director,
         officer,  employee, or agent of the corporation or is or was serving at
         the request of the  corporation as a director,  officer,  employee,  or
         agent of another  corporation,  partnership,  joint venture,  trust, or
         other  enterprise  against  liability  incurred in connection with such
         proceeding, including any appeal thereof, if he acted in good faith and
         in a manner he  reasonably  believed  to be in, or not  opposed to, the
         best  interests of the  corporation  and,  with respect to any criminal
         action or  proceeding,  had no reasonable  cause to believe his conduct
         was unlawful.  The  termination of any  proceeding by judgment,  order,
         settlement,  or  conviction  or upon a plea of nolo  contendere  or its
         equivalent  shall not, of itself,  create a presumption that the person
         did not act in good faith and in a manner which he reasonably  believed

                                      II-1





         to be in, or not opposed to, the best interests of the  corporation or,
         with respect to any criminal action or proceeding, had reasonable cause
         to believe that his conduct was unlawful.

(2)      A corporation shall have power to indemnify any person, who was or is a
         party  to any  proceeding  by or in the  right  of the  corporation  to
         procure a judgment in its favor by reason of the fact that he is or was
         a director, officer, employee, or agent of the corporation or is or was
         serving  at the  request of the  corporation  as a  director,  officer,
         employee, or agent of another corporation,  partnership, joint venture,
         trust,  or other  enterprise,  against  expenses  and  amounts  paid in
         settlement  not  exceeding,  in the judgment of the board of directors,
         the estimated  expense of  litigating  the  proceeding  to  conclusion,
         actually  and  reasonably  incurred in  connection  with the defense or
         settlement  of such  proceeding,  including  any appeal  thereof.  Such
         indemnification  shall be authorized if such person acted in good faith
         and in a manner he reasonably believed to be in, or not opposed to, the
         best interests of the corporation, except that no indemnification shall
         be made under this subsection in respect of any claim, issue, or matter
         as to which such person shall have been  adjudged to be liable  unless,
         and only to the extent  that,  the court in which such  proceeding  was
         brought, or any other court of competent jurisdiction,  shall determine
         upon  application  that,  despite the  adjudication of liability but in
         view of all  circumstances  of the case,  such  person  is  fairly  and
         reasonably  entitled to indemnity  for such  expenses  which such court
         shall deem proper.

(3)      To the  extent  that a  director,  officer,  employee,  or  agent  of a
         corporation  has been  successful on the merits or otherwise in defense
         of any proceeding  referred to in subsection (1) or subsection  (2), or
         in  defense  of any  claim,  issue,  or  matter  therein,  he  shall be
         indemnified against expenses actually and reasonably incurred by him in
         connection therewith.

(4)      Any  indemnification  under  subsection (1) or subsection  (2),  unless
         pursuant  to  a  determination  by  a  court,  shall  be  made  by  the
         corporation   only  as   authorized   in  the  specific   case  upon  a
         determination that indemnification of the director,  officer, employee,
         or  agent  is  proper  in the  circumstances  because  he has  met  the
         applicable   standard  of  conduct  set  forth  in  subsection  (1)  or
         subsection (2). Such determination shall be made:

         (a)      By the  board  of  directors  by a  majority  vote of a quorum
                  consisting   of  directors   who  were  not  parties  to  such
                  proceeding;

         (b)      If such a quorum is not obtainable or, even if obtainable,  by
                  majority vote of a committee  duly  designated by the board of
                  directors (in which directors who are parties may participate)
                  consisting  solely  of two or more  directors  not at the time
                  parties to the proceeding;

         (c)      By independent legal counsel:

                  1.     Selected  by  the  board  of  directors  prescribed  in
                         paragraph (a) or the committee  prescribed in paragraph
                         (b); or

                  2.     If a quorum of the  directors  cannot be  obtained  for
                         paragraph  (a) and the  committee  cannot be designated
                         under  paragraph (b),  selected by majority vote of the

                                      II-2





                         full board of  directors  (in which  directors  who are
                         parties may participate); or

         (d)      By the shareholders by a majority vote of a quorum  consisting
                  of shareholders who were not parties to such proceeding or, if
                  no  such  quorum  is   obtainable,   by  a  majority  vote  of
                  shareholders who were not parties to such proceeding.

(5)      Evaluation  of the  reasonableness  of expenses  and  authorization  of
         indemnification  shall be made in the same manner as the  determination
         that  indemnification is permissible.  However, if the determination of
         permissibility is made by independent legal counsel,  persons specified
         by paragraph (4)(c) shall evaluate the  reasonableness  of expenses and
         may authorize indemnification.

(6)      Expenses  incurred by an officer or  director  in  defending a civil or
         criminal  proceeding  may be paid by the  corporation in advance of the
         final  disposition of such proceeding upon receipt of an undertaking by
         or on behalf of such  director or officer to repay such amount if he is
         ultimately  found  not  to  be  entitled  to   indemnification  by  the
         corporation  pursuant  to this  section.  Expenses  incurred  by  other
         employees  and  agents  may be paid  in  advance  upon  such  terms  or
         conditions that the board of directors deems appropriate.

(7)      The  indemnification  and advancement of expenses  provided pursuant to
         this section are not exclusive, and a corporation may make any other or
         further  indemnification  or  advancement  of  expenses  of  any of its
         directors,  officers, employees, or agents, under any bylaw, agreement,
         vote of shareholders or disinterested directors, or otherwise,  both as
         to action in his official capacity and as to action in another capacity
         while holding such office.  However,  indemnification or advancement of
         expenses  shall not be made to or on behalf of any  director,  officer,
         employee,   or  agent  if  a  judgment  or  other  final   adjudication
         establishes that his actions, or omissions to act, were material to the
         cause of action so adjudicated and constitute:

         (a)      A violation of the criminal law, unless the director, officer,
                  employee, or agent had reasonable cause to believe his conduct
                  was lawful or had no  reasonable  cause to believe his conduct
                  was unlawful;

         (b)      A transaction from which the director,  officer,  employee, or
                  agent derived an improper personal benefit;

         (c)      In the case of a  director,  a  circumstance  under  which the
                  liability provisions of s. 607.0834 are applicable; or

         (d)      Willful  misconduct  or a  conscious  disregard  for the  best
                  interests  of the  corporation  in a  proceeding  by or in the
                  right of the corporation to procure a judgment in its favor or
                  in a proceeding by or in the right of a shareholder.

(8)      Indemnification and advancement of expenses as provided in this section
         shall  continue  as,  unless  otherwise  provided  when  authorized  or
         ratified,  to a  person  who  has  ceased  to be a  director,  officer,
         employee,  or agent  and  shall  inure  to the  benefit  of the  heirs,
         executors,  and  administrators  of  such a  person,  unless  otherwise
         provided when authorized or ratified.

                                      II-3





(9)      Unless the corporation's  articles of incorporation  provide otherwise,
         notwithstanding    the   failure   of   a   corporation    to   provide
         indemnification, and despite any contrary determination of the board or
         of  the  shareholders  in  the  specific  case,  a  director,  officer,
         employee,  or  agent  of the  corporation  who is or was a  party  to a
         proceeding may apply for indemnification or advancement of expenses, or
         both to the court  conducting the proceeding,  to the circuit court, or
         to  another  court  of  competent   jurisdiction.   On  receipt  of  an
         application,  the court,  after  giving any  notice  that it  considers
         necessary,  may order  indemnification  and  advancement  of  expenses,
         including expenses incurred in seeking court-ordered indemnification or
         advancement of expenses, if it determines that:

         (a)      The  director,  officer,  employee,  or agent is  entitled  to
                  mandatory  indemnification under subsection (3), in which case
                  the court shall also order the corporation to pay the director
                  reasonable   expenses  incurred  in  obtaining   court-ordered
                  indemnification or advancement of expenses;

         (b)      The  director,  officer,  employee,  or agent is  entitled  to
                  indemnification or advancement of expenses, or both, by virtue
                  of the exercise by the  corporation  of its power  pursuant to
                  subsection (7); or

         (c)      The  director,  officer,  employee,  or  agent is  fairly  and
                  reasonably  entitled  to  indemnification  or  advancement  of
                  expenses, or both, in view of all the relevant  circumstances,
                  regardless  of whether such person met the standard of conduct
                  set forth in subsection (1) subsection (2), or subsection (7).

(10)     For  purposes of this  section,  the term  "corporation"  includes,  in
         addition to the  resulting  corporation,  any  constituent  corporation
         (including   any   constituent   of  a   constituent)   absorbed  in  a
         consolidation  or merger,  so that any person who is or was a director,
         officer, employee, or agent of a constituent corporation,  or is or was
         serving at the  request of a  constituent  corporation  as a  director,
         officer, employee, or agent of another corporation,  partnership, joint
         venture, trust, or other enterprise, is in the same position under this
         section with respect to the  resulting or surviving  corporation  as he
         would have with respect to such constituent corporation if its separate
         existence had continued.

For purposes of this section:

         (a)      The term "other enterprises" includes employee benefit plans;

         (b)      The term "expenses" includes counsel fees, including those for
                  appeal;

         (c)      The term "liability"  includes  obligations to pay a judgment,
                  settlement,  penalty,  fine  (including an excise tax assessed
                  with  respect to any  employee  benefit  plan),  and  expenses
                  actually and reasonably incurred with respect to a proceeding;

         (d)      The term  "proceeding"  includes any threatened,  pending,  or
                  completed action,  suit, or other type of proceeding,  whether
                  civil, criminal,  administrative, or investigative and whether
                  formal or informal;

         (e)      The term "agent" includes a volunteer;

                                      II-4





         (f)      The term "serving at the request of the corporation"  includes
                  any service as a director,  officer, employee, or agent of the
                  corporation  that imposes  duties on such  persons,  including
                  duties   relating  to  an  employee   benefit   plan  and  its
                  participants or beneficiaries; and

         (g)      The term "not opposed to the best interest of the corporation"
                  describes  the  actions of a person who acts in good faith and
                  in a manner he reasonably believes to be in the best interests
                  of the participants  and  beneficiaries of an employee benefit
                  plan.

(12)     A  corporation  shall have power to purchase and maintain  insurance on
         behalf of any person who is or was a director,  officer,  employee,  or
         agent of the  corporation  or is or was  serving at the  request of the
         corporation  as a  director,  officer,  employee,  or agent of  another
         corporation,  partnership,  joint venture,  trust, or other  enterprise
         against any liability  asserted  against him and incurred by him in any
         such capacity or arising out of his status as such,  whether or not the
         corporation  would  have  the  power  to  indemnify  him  against  such
         liability under the provisions of this section.

         The Company has also agreed to indemnify  each  director and  executive
         officer  pursuant  to  an  Indemnification  Agreement  with  each  such
         director and  executive  officer from and against any and all expenses,
         losses,  claims,  damages and  liability  incurred by such  director or
         executive officer for or as a result of action taken or not taken while
         such  director or  executive  officer  was acting in his  capacity as a
         director,  officer,  employee or agent of the  Company,  to the fullest
         extent permitted under Florida law.

         The Registration Rights Agreement by and among the selling shareholders
         and us,  provides  that  we will  indemnify  the  selling  shareholders
         against certain liabilities, including liabilities under the Securities
         Act of 1933 and the  selling  shareholders  will  indemnify  us and our
         executive officers and directors against certain liabilities, including
         liabilities under the Securities Act.

         Insofar as indemnification for liabilities arising under the Securities
         Act may be permitted to directors,  officers, or persons controlling us
         pursuant to the foregoing provisions, we have been informed that in the
         opinion of the SEC such  indemnification  is against  public  policy as
         expressed in the Securities Act and is therefore unenforceable.

ITEM 16.    Exhibits.
-------     --------

Exhibit No.

    4.1     Specimen  Certificate of the Registrant's Common Stock (incorporated
            by reference to the Registrant's  registration statement on Form 8-A
            dated December 11, 1995).

   *4.2     Registration  Rights  Agreement  dated as of August 22,  2002 by and
            among the Registrant and the selling shareholders named therein.

    5.1     Opinion  of Olshan  Grundman  Frome  Rosenzweig  & Wolosky  LLP with
            respect to legality of the Common Stock.

   23.1     Consent  of  Margolin,   Winer  &  Evens  LLP,   independent  public
            accountants.

                                      II-5





    23.2    Consent of Olshan Grundman Frome Rosenzweig & Wolosky LLP,  included
            in Exhibit No. 5.1.

   *24.1    Power  of  Attorney,   included  on  the  signature   page  to  this
            Registration Statement.

   ---------------------------
   *        Previously filed.


ITEM 17.    Undertakings.
-------     ------------


     (a)    The undersigned registrant hereby undertakes:

            (1) To file,  during any  period in which  offers or sales are being
made, a post-effective amendment to this registration statement:

                (i) To include any  prospectus  required by Section  10(a)(3) of
      the Securities Act of 1933;

                (ii) To reflect in the  prospectus  any facts or events  arising
      after the effective date of the registration statement (or the most recent
      post-effective amendment thereof) which, individually or in the aggregate,
      represent  a  fundamental  change  in the  information  set  forth  in the
      registration  statement.  Notwithstanding  the foregoing,  any increase or
      decrease in volume of  securities  offered (if the total  dollar  value of
      securities  offered  would not exceed that which was  registered)  and any
      deviation from the low or high end of the estimated maximum offering range
      may be  reflected  in the form of  prospectus  filed  with the  Commission
      pursuant  to Rule 424(b) if, in the  aggregate,  the changes in volume and
      price  represent no more than 20 percent  change in the maximum  aggregate
      offering price set forth in the "Calculation of Registration Fee" table in
      the effective registration statement.

                (iii) To include any  material  information  with respect to the
      plan  of  distribution  not  previously   disclosed  in  the  registration
      statement or any material change to such  information in the  registration
      statement;

            (2) That,  for the purpose of  determining  any liability  under the
Securities Act, each such  post-effective  amendment shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

            (3)  To  remove  from  registration  by  means  of a  post-effective
amendment  any of the  securities  being  registered  which remain unsold at the
termination of the offering.


      (b)   The undersigned  registrant  hereby  undertakes  that, for purposes
of  determining  any  liability  under the  Securities  Act,  each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange Act of 1934, as amended,  that is incorporated by reference
in the Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

                                      II-6





      (c)   Insofar  as  indemnification   for  liabilities   arising  under
the Securities Act of 1933, as amended (the  "Securities  Act") may be permitted
to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions,  or otherwise, the registrant has been advised that in the
opinion of the  Securities  and  Exchange  Commission  such  indemnification  is
against  public  policy as expressed in the  Securities  Act and is,  therefore,
unenforceable.  In the  event  that a claim  for  indemnification  against  such
liabilities  (other than the payment by the  registrant of expenses  incurred or
paid by a  director,  officer or  controlling  person of the  registrant  in the
successful  defense  of an  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as  expressed  in the  Securities  Act and will be  governed by the final
adjudication of such issue.

                                      II-7





                                   SIGNATURES


            Pursuant to the  requirements  of the  Securities  Act of 1933,  the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this registration
statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the City of Stuart, State of Florida on the 24th day of October,
2002.



                                  NuCo2 Inc.
                                  ----------------------------------------------
                                  (Registrant)

                                  By:/s/ Michael E. DeDomenico
                                     -------------------------------------------
                                     Michael E. DeDomenico
                                     Chief Executive Officer

            Pursuant  to the  requirements  of the  Securities  Act of 1933,  as
amended, this Registration Statement has been signed by the following persons in
the capacities and on the date indicated.

                                    Chairman of the Board and
/s/ Michael E. DeDemonico           Chief Executive Officer              October 24, 2002
-----------------------------       (Principal Executive Officer)
(Michael E. DeDomenico)

                                    Chief Financial Officer
/s/ Gregg F. Stewart                Principal Financial Officer          October 24, 2002
-----------------------------       and Principal Accounting Officer)
(Gregg F. Stewart)

                                    Director
-----------------------------
(Craig L. Burr)

            *                       Director                             October 24, 2002
-----------------------------
(Robert L. Frome)


            *                       Director                             October 24, 2002
-----------------------------
(Daniel Raynor)

                                    Director
-----------------------------
(John L. Walsh)

            *                       Director                             October 24, 2002
-----------------------------
(Richard D. Waters, Jr.)

            *                       Director                             October 24, 2002
-----------------------------
(John E. Wilson)

*     By:     /s/ Eric M. Wechsler
              --------------------
              Eric M. Wechsler
              Attorney-in-fact

                                      II-8





                                  EXHIBIT INDEX

Exhibit No.

     4.1       Specimen   Certificate   of   the   Registrant's   Common   Stock
               (incorporated  by  reference  to  the  Registrant's  registration
               statement on Form 8-A dated December 11, 1995).

    *4.2       Registration  Rights Agreement dated as of August 22, 2002 by and
               among the Registrant and the selling shareholders named therein.

     5.1       Opinion of Olshan  Grundman  Frome  Rosenzweig & Wolosky LLP with
               respect to legality of the Common Stock.

    23.1       Consent  of  Margolin,  Winer &  Evens  LLP,  independent  public
               accountants.

    23.2       Consent  of Olshan  Grundman  Frome  Rosenzweig  &  Wolosky  LLP,
               included in Exhibit No. 5.1.

   *24.1       Power  of  Attorney,  included  on the  signature  page  to  this
               Registration Statement.

  ---------------------------
  *            Previously filed.

                                      II-9